March 11, 2026 · Form 4 insider transaction
McKechnie Duncan sold 2,633 shares of Vertex Pharmaceuticals Incorporated at $498.42 per share, a transaction worth $1.31M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Mr. McKechnie's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025.